Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: Continuous or discontinuous?

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Nakayama, Takahisa ^a   Ling, Zhi Qiang ^a,b   Mukaisho, Ken ichi ^a   Hattori, Takanori ^a   Sugihara, Hiroyuki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; MYC PROTEIN; PROTEIN P53; MYC PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 4Q; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EARLY CANCER; EXON; FEMALE; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; SEQUENCE ANALYSIS; STOMACH ADENOCARCINOMA; SUBMUCOSA; ADENOCARCINOMA; CANCER STAGING; CELL LINEAGE; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PHENOTYPE; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL LINEAGE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GASTRIC MUCOSA; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953655010     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-311     Document Type: Article

References (36)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
3. Carneiro F. Classification of gastric carcinomas. Curr Diagn Pathol 1997, 4:51-59.
4. Jass JR. Tumour of the stomach. Oxford Textbook of Pathology 1992, 1165-1173. Oxford: Oxford University Press, McGee JO'D, Isaacson PG, Wright NA.
5. Tsukuma H, Mishima T, Oshima A. Prospective study of "early" gastric cancer. Int J Cancer 1983, 31:421-426. 10.1002/ijc.2910310405, 6832853.
6. Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 2000, 47:618-621. 10.1136/gut.47.5.618, 1728114, 11034575.
7. Hirota T, Ming SC, Itabashi M. Pathology of early gastric cancer. Gastric Cancer 1993, 66-87. Tokyo: Springer-Verlag, Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E.
8. Sawada T, Nakata T, Takasugi N, Maeda K, Hanawa Y, Shimizu K, Hirayama M, Takeda T, Mori T, Koide R, Tsunoda A, Nagahara N, Yamamoto K. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group. Lancet 1984, 2(8397):271-273. 10.1016/S0140-6736(84)90311-8, 6146820.
9. Sawada T, Sugimoto T, Tanaka T, Kawakatsu H, Ishii T, Matsumura T, Horii Y. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects. Med Pediatr Oncol 1987, 15:14-17. 10.1002/mpo.2950150104, 3561327.
10. Murphy SB, Cohn SL, Craft AW, Woods WG, Sawada T, Castleberry RP, Levy HL, Prorok PC, Hammond GD. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet 1991, 337(8737):344-6. 10.1016/0140-6736(91)90957-Q, 1671243.
11. Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 1987, 47:311-318.
12. Kaneko Y, Kobayashi H, Watanabe N, Tomioka N, Nakagawara A. Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan. Pediatr Blood Cancer 2006, 46:285-291. 10.1002/pbc.20496, 16078225.
13. Ullmann R, Bongiovanni M, Halbwedl I, Fraire AE, Cagle PT, Mori M, Papotti M, Popper HH. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?. J Pathol 2003, 201:371-376. 10.1002/path.1460, 14595748.
14. Sugihara H, Hattori T, Fukuda M, Fujita S. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A Pathol Anat Histopathol 1987, 411:117-127. 10.1007/BF00712735, 3037769.
15. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol 2003, 201:439-450. 10.1002/path.1459, 14595756.
16. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J Pathol 2004, 203:884-895. 10.1002/path.1586, 15258990.
17. Yoshimura A, Sugihara H, Ling ZQ, Peng DF, Mukaisho K, Fujiyama Y, Hattori T. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53. Pathobiology 2006, 73:40-49. 10.1159/000093090, 16785766.
18. Kushima R, Mukaisho K, Tshukashita S, Peng D, Sugihara H, Vieth M, Stolte M, Hattori T. Molecular biological characteristics of early stomach adenocarcinomas of the completely gastric phenotype revealed by laser capture microdissection and comparative genomic hybridization. Stomach and Intestine (Tokyo) 38:707-721.
19. Japanese Gastric Cancer Association Japanese Classification of Gastric Carcinoma - 2nd English Edition -. Gastric Cancer 1998, 1:10-24. Japanese Gastric Cancer Association.
20. Kamitani S, Sugihara H, Shiomi H, Tani T, Hattori T. Intratumoral regional variations in copy number of the chromosomal part revealed by microdissection and combined ploidy and comparative genomic hybridization analyses in esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2002, 132:30-35. 10.1016/S0165-4608(01)00520-9, 11801305.
21. Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C. Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. Genomics 2006, 87:298-306. 10.1016/j.ygeno.2005.09.019, 16271290.
22. Okada K, Sugihara H, Bamba M, Bamba T, Hattori T. Sequential numerical changes of chromosomes 7 and 18 in diffuse-type stomach cancer cell lines: combined comparative genomic hybridization, fluorescence in situ hybridization, and ploidy analyses. Cancer Genet Cytogenetl 2000, 118:99-107.
23. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M, Shimano T, Mori T. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 1994, 54:4798-4804.
24. Zhou X, Mok SC, Chen Z, Li Y, Wong DTW. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CAN) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum Genet 2004, 115:327-330. 10.1007/s00439-004-1163-1, 15290239.
25. Melcher R, Al-Taie O, Kudlich T, Hartmann E, Maisch S, Steinlein C, Schmid M, Rosenwald A, Menzel T, Scheppach W, Luhrs H. SNP-Array genotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS- and MSI-colorectal cancer cell lines. Cytogenet Genome Res 2007, 118:214-221. 10.1159/000108303, 18000373.
26. Tsubosa Y, Sugihara H, Mukaisho K, Kamitani S, Peng DF, Ling ZQ, Tani T, Hattori T. Effects of degenerate oligonucleotide-primed polymerase chain reaction amplification and labeling methods on the sensitivity and specificity of metaphase- and array-based comparat.
27. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999, 24:299-305. 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U, 10092127.
28. Guan XY, Fu SB, Xia JC, Fang Y, Sham JS, Du BD, Zhou H, Lu S, Wang BQ, Lin YZ, Liang Q, Li XM, Du B, Ning XM, Du JR, Li P, Trent JM. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenetl 2000, 123:27-34.
29. Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim SH, Noh SM. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence In situ hybridization studies. Cancer Genet Cytogenet 2000, 117:97-103. 10.1016/S0165-4608(99)00152-1, 10704677.
30. Kong G, Oga A, Park CK, Kawauchi S, Furuya T, Sasaki K. DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma. Jpn J Cancer Res 2001, 92:740-747.
31. Hirota T, Itabashi M, Suzuki K, Yoshida S. Clinicopathologic study of minute and small early gastric cancer. Histogenesis of gastric cancer. Pathol Annu 1980, 15(Pt 2):1-19.
32. Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998, 152:1107-1123. 1858578, 9588877.
33. Chung YJ, Choi JR, Park SW, Kim KM, Rhyu MG. Evidence for two modes of allelic loss: multifocal analysis on both early and advanced gastric carcinomas. Virchows Arch 2001, 438:31-38. 10.1007/s004280000328, 11213833.
34. Sugai T, Habano W, Uesugi N, Jao YF, Nakamura S, Abe K, Takagane A, Terashima M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol 2004, 17:1223-1234. 10.1038/modpathol.3800170, 15154009.
35. Tajima Y, Yamazaki K, Makino R, Nishino N, Aoki S, Kato M, Morohara K, Kaetsu T, Kusano M. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006, 12:6469-6479. 10.1158/1078-0432.CCR-06-1339, 17085661.
36. Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 2003, 1:1001-1008.